PER 0.00% 10.0¢ percheron therapeutics limited

various models on licensing negotiation , page-2

  1. 88 Posts.
    Great link Skyrocketer.

    By looking at the presentation, companies get bigger deals in pre Phase 3 trials.

    So I am guessing for ATL 1103 we might get between $10 to $20 Million upfront payment plus further payments on milestones achieved.

    If the deal with Chinese go through as well, conservatively we are looking at a target of 4c by end of this year.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.